The potency ratio fluticasone propionate / budesonide

B. Stallberg, E. Pilman, B. E. Skoogh, B. A. Hermansson (Trosa, Helsingborg, Sweden)

Source: Annual Congress 2003 - Advances in our understanding of corticosteroids in the treatment of asthma
Session: Advances in our understanding of corticosteroids in the treatment of asthma
Session type: Poster Discussion
Number: 334
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Stallberg, E. Pilman, B. E. Skoogh, B. A. Hermansson (Trosa, Helsingborg, Sweden). The potency ratio fluticasone propionate / budesonide. Eur Respir J 2003; 22: Suppl. 45, 334

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of inhaled ciclesonide, fluticasone propinate and fluticasone propionate + salmeterol in maintaining asthma control
Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Year: 2009

Efficacy of salmeterol/fluticasone propionate MDI versus higher dose fluticasone propionate in adolescent and adult asthmatics uncontrolled on fluticasone propionate alone
Source: Eur Respir J 2003; 22: Suppl. 45, 438s
Year: 2003

Comparison of fluticasone propionate plus theophylline with the salmeterol/fluticasone propionate combination in Japanese asthmatics
Source: Eur Respir J 2005; 26: Suppl. 49, 44s
Year: 2005

Variable lipophilicity of budesonide: Comparison with fluticasone propionate, mometasone furoate, and ciclesonide
Source: Eur Respir J 2003; 22: Suppl. 45, 33s
Year: 2003

Relative potency of beclomethasone propionate (BDP), delivered by HFA-MDI, and fluticasone propionate (FP) delivered by diskus
Source: Eur Respir J 2003; 22: Suppl. 45, 236s
Year: 2003

Initial maintenance therapy with fluticasone propionate/ salmeterol combination product provides superior asthma control versus montelukast or fluticasone propionate alone
Source: Eur Respir J 2002; 20: Suppl. 38, 386s
Year: 2002

Timecourse of action of two inhaled corticosteroids, fluticasone propionate and budesonide
Source: Eur Respir J 2002; 20: Suppl. 38, 308s
Year: 2002

Salmeterol/fluticasone propionate combination (SFC) versus doubling dose of fluticasone propionate (FP) in children with asthma insufficiently controlled on moderate doses of inhaled corticosteroids
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010


Effect of fluticasone propionate (FP)/salmeterol 100/50mcg or FP 250mcg on small airway function
Source: Eur Respir J 2003; 22: Suppl. 45, 260s
Year: 2003

The effects of fluticasone propionate/salmeterole 50/100 μg bid in children with asthma versus beclometasone propionate 200 μg BD and fluticasone propionate 100 μg bid dry powder inhaletors
Source: Eur Respir J 2004; 24: Suppl. 48, 378s
Year: 2004

QVAR pMDI is more cost-effective than fluticasone propionate (FP) or CFC-beclometasone dipropionate (BDP) PMDI in a real-life asthmatic population receiving an increase in ICS dose
Source: Annual Congress 2009 - Sustainability in treatment of COPD patients according to economics and quality of care
Year: 2009

Inhibition of allergen-iduced late asthmatic reaction by montelukast versus fluticasone propionate
Source: Eur Respir J 2003; 22: Suppl. 45, 349s
Year: 2003

Budesonide is better retained in airway tissue than fluticasone propionate and mometasone furoate due to the formation of lipophilic, slowly hydrolyzed budesonide esters
Source: Eur Respir J 2003; 22: Suppl. 45, 281s
Year: 2003

Higher cellular retention and activity after pulse exposure by budesonide (BUD) than fluticasone propionate (FP) and mometasone furoate (MF)
Source: Eur Respir J 2001; 18: Suppl. 33, 158s
Year: 2001

Synergy with salmeterol and fluticasone propionate after administration from a single inhaler (Seretide™)
Source: Eur Respir J 2001; 18: Suppl. 33, 176s
Year: 2001

Once-daily, high-dose inhaled fluticasone propionate and salmeterol in patients having moderate asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 125s
Year: 2004

Incidence of oral candidiasis during treatmet with fluticasone propionate versus beclomethasone dipropionate
Source: Eur Respir J 2006; 28: Suppl. 50, 314s
Year: 2006

Fluticasone propionate/formoterol fumarate combination therapy is more effective than fluticasone propionate alone in the treatment of asthma
Source: Annual Congress 2010 - Combination therapy in asthma and COPD
Year: 2010

Fluticasone propionate/formoterol fumarate combination therapy has superior efficacy to both fluticasone and formoterol alone
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011

Clinical efficacy of once-daily mometasone furoate in children with persistent asthma switched from treatment with fluticasone propionate
Source: Annual Congress 2011 - Airways disease comorbidities and general aspects
Year: 2011